The fight against advanced chronic liver disease (ACLD) is gaining a crucial, targeted weapon: beta-blockers, particularly carvedilol. A new review underscores their…
Source link
The fight against advanced chronic liver disease (ACLD) is gaining a crucial, targeted weapon: beta-blockers, particularly carvedilol. A new review underscores their…
Source link